A. Inhibition of cyclooxygenase with reduced prostaglandin E2 production
Why this is correct
Prostaglandins, particularly PGE2, maintain ductal patency in fetal life. Cyclooxygenase inhibitors such as ibuprofen or indomethacin reduce prostaglandin synthesis, promoting smooth-muscle constriction and functional closure when clinically appropriate. The contrasting strategy is alprostadil (PGE1), which maintains ductal patency in selected duct-dependent congenital cardiac lesions.
Why each option is correct or incorrect
Correct: COX inhibition lowers prostaglandin synthesis and can constrict the ductus.
PGE1 is administered to keep a duct open in duct-dependent lesions.
Beta-2 stimulation is not the standard mechanism of pharmacologic ductal closure.
Increased nitric oxide tends to favor smooth-muscle relaxation, not ductal constriction.
High-yield notes
- PDA causes a continuous murmur and widened pulse pressure.
- NSAIDs can close PDA when suitable; clinical selection depends on neonatal factors.
- PGE1 infusion maintains ductal flow in duct-dependent congenital heart disease.
Remember the opposite drug effects: indomethacin/ibuprofen close; alprostadil keeps open.
An NSAID is not appropriate in every premature infant or every cardiac defect; duct dependence must be excluded.